New combo therapy aims to shrink abdominal tumors in colorectal cancer patients
Disease control
Not yet recruiting
This study tests whether adding two drugs (pirfenidone and sintilimab) to standard chemotherapy can shrink tumors in people with colorectal cancer that has spread to the lining of the abdomen. About 30 adults aged 18 to 75 will receive the treatment for 4 cycles, then doctors wil…
Phase: PHASE2 • Sponsor: Guoxiang Cai • Aim: Disease control
Last updated May 13, 2026 16:01 UTC